Leteprinim (Neotrofin AIT-082) is a hypoxanthine derivative drug with neuroprotective and nootropic effects. It stimulates release of nerve growth factors and enhances survival of neurons in the brain and is under development as a potential treatment for neurodegenerative disorders such as Alzheimer’s disease Parkinson’s disease and stroke.
This page contains content from the copyrighted Wikipedia article "Leteprinim"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
